Multiple sclerosis lymphocytes upregulate A2Aadenosine receptors that are antiinflammatory when stimulated

New and emerging disease modifying therapies for multiple sclerosis

(2012) Shiv Saidha et al.   Annals of the New York Academy of Sciences

Immune Therapy of Multiple Sclerosis - Future Strategies

(2012) Sven G. Meuth et al.   CURRENT PHARMACEUTICAL DESIGN

Biologic Therapies: Lessons from Multiple Sclerosis

(2012) Subrata Ghosh   DIGESTIVE DISEASES

Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies

(2012) Amedeo Amedei et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis

(2012) J. H. Mills et al.   JOURNAL OF IMMUNOLOGY

Genetic inactivation of the adenosine A2Areceptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis

(2012) Shu-Qin Yao et al.   JOURNAL OF NEUROCHEMISTRY

Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling

(2012) J. M. Martinez Gomez et al.   JOURNAL OF NEUROSCIENCE

Lethal multiple sclerosis relapse after natalizumab withdrawal

(2012) V. Rigau et al.   NEUROLOGY

Additive effect of prostaglandin E2 and adenosine in mouse experimental autoimmune encephalomyelitis

(2012) JingJing Xu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Current and emerging therapies in multiple sclerosis: a systematic review

(2012) Wanda Castro-Borrero et al.   Therapeutic Advances in Neurological Disorders

Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay

(2011) Thomas B. Martins et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Immunopathogenesis of multiple sclerosis

(2011) Manuel Comabella et al.   CLINICAL IMMUNOLOGY

Adenosine receptor targeting in health and disease

(2011) Stefania Gessi et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Modulation of Innate Immunity by Adenosine Receptor Stimulation

(2011) Bart P. Ramakers et al.   SHOCK

Anti-Inflammatory and Immunosuppressive Effects of the A2AAdenosine Receptor

(2011) Gillian R. Milne et al.   TheScientificWorldJOURNAL

A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release

(2011) Katia Varani et al.   ARTHRITIS RESEARCH & THERAPY

A3Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-κB Pathway

(2010) Katia Varani et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The blood–brain barrier, chemokines and multiple sclerosis

(2010) David W. Holman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes

(2010) K Varani et al.   BRITISH JOURNAL OF PHARMACOLOGY

Normalization of A2Aand A3adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate

(2009) Katia Varani et al.   ARTHRITIS AND RHEUMATISM

NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis

(2009) J. Yan et al.   CNS & Neurological Disorders-Drug Targets

A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson’s disease

(2009) Katia Varani et al.   FASEB JOURNAL

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

(2008) György Haskó et al.   NATURE REVIEWS DRUG DISCOVERY

Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction

(2007) T M Palmer et al.   BRITISH JOURNAL OF PHARMACOLOGY